Wells Fargo & Company MN Has $3.94 Million Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Wells Fargo & Company MN cut its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 2.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 59,880 shares of the company’s stock after selling 1,492 shares during the period. Wells Fargo & Company MN’s holdings in iShares U.S. Pharmaceuticals ETF were worth $3,935,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently modified their holdings of the stock. Jane Street Group LLC raised its holdings in iShares U.S. Pharmaceuticals ETF by 5.5% in the 3rd quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock valued at $836,000 after acquiring an additional 616 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in iShares U.S. Pharmaceuticals ETF by 11.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock valued at $253,000 after acquiring an additional 356 shares during the last quarter. Capital Investment Advisors LLC boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 48.2% in the 4th quarter. Capital Investment Advisors LLC now owns 5,386 shares of the company’s stock valued at $354,000 after purchasing an additional 1,751 shares in the last quarter. Pallas Capital Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth $3,829,000. Finally, Wealthcare Advisory Partners LLC boosted its stake in iShares U.S. Pharmaceuticals ETF by 15.0% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 5,178 shares of the company’s stock valued at $340,000 after buying an additional 675 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Down 1.2 %

Shares of NYSEARCA IHE opened at $64.00 on Tuesday. The stock has a 50-day moving average price of $68.37 and a two-hundred day moving average price of $68.39. iShares U.S. Pharmaceuticals ETF has a 12 month low of $58.97 and a 12 month high of $73.28. The company has a market cap of $582.40 million, a price-to-earnings ratio of 21.53 and a beta of 0.63.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.